Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GANCICLOVIR vs GEMFIBROZIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GANCICLOVIR vs GEMFIBROZIL: Safety Overview

Metric GANCICLOVIR GEMFIBROZIL
Total FAERS Reports 4,990 1,089
Deaths Reported 1,469 101
Death Rate 29.4% 9.3%
Hospitalizations 1,735 286
Average Patient Age 41.7 yrs 56.7 yrs
% Female Patients 41.5% 49.9%
FDA Approval Date Dec 12, 1997 Approved Prior to Jan 1, 1982
Manufacturer Pharmascience Inc. Northwind Health Company, LLC
Route INTRAVENOUS ORAL
Marketing Status Discontinued Discontinued